the carrier matters more than the distance, and that is the thing this channel took two years to agree on
#asia 2025-09-21
- factory_direct_fi — update on the earlier thing customs between asian countries has not been noticeably easier in anything members have reported. each border is its own border 18:18
- bengaluru_bac — india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every… 18:56
- coa_or_cope — update from 4 months ago: availability in the region is broadly the same and the prices i track are slightly higher 19:20
- quiet_head_qi — the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is still not a guarantee about the vial you… 20:11
korea has a clinic culture where this is straightforward to obtain, and members reported that as both a convenience and a concern, happy to be corrected
approval isnt cheap
forty percent apart
update on the earlier thing customs between asian countries has not been noticeably easier in anything members have reported. each border is its own border
a member in tokyo reported an out of pocket cost in the region of twenty thousand yen a month in 2024, at a clinic, still working it out
japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price
japan approved it
is anyone here avoiding summer shipping the way the australians do
anyone had a parcel stopped moving between two asian countries
for the archive generics being available and generics being right for your situation are different questions, and only one of them is a chat question
india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every single time
is it covered by insurance anywhere in the region
transit inside the region ran 22 days for me, which was not faster than a longer route with a better carrier
update from 4 months ago: availability in the region is broadly the same and the prices i track are slightly higher
hong kong, is it pharmacy or clinic in practice
does a closer supplier actually mean fewer customs steps
is it easier to get seen about this in korea than in europe
figures are from last year
i treat a claim about an indian generic the way i treat any claim about any product. get a lot number and get it tested
the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is still not a guarantee about the vial you received
lot number first
the carrier matters
thailand and taiwan come up occasionally and we have almost no member reports from either, so i would not guess
the honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way
*Medutest not the other one